Unknown

Dataset Information

0

Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019

ABSTRACT: Abstract We characterized the antibody composition of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) and the immunologic responses of hospitalized COVID-19 patients after receiving CCP or nonimmune fresh frozen plasma. Despite selection of CCP with significantly higher total immunoglobulin G than recipients, neutralizing antibody levels did not differ between donor plasma and CCP recipients.

SUBMITTER: Bainbridge E 

PROVIDER: S-EPMC8344822 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown High-titer convalescent plasma therapy for coronavirus disease 2019 and mortality.
| S-EPMC8242638 | biostudies-literature
Unknown Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients.
| S-EPMC8083369 | biostudies-literature
Unknown Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study.
| S-EPMC7665324 | biostudies-literature
Unknown Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.
| S-EPMC8447161 | biostudies-literature
Unknown Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy.
| S-EPMC7536086 | biostudies-literature
Unknown Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma.
| S-EPMC7717355 | biostudies-literature
Unknown Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
| S-EPMC7454720 | biostudies-literature
Unknown Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma.
| S-EPMC7251400 | biostudies-literature
Unknown Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG.
| S-EPMC7609241 | biostudies-literature
Unknown Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan.
| S-EPMC7450236 | biostudies-literature